{"id":"W3129780093","doi":"10.1016/s0140-6736(21)00152-5","title":"A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; National Institutes of Health; Wayne State University","keywords":"Cabozantinib; Sunitinib; Medicine; Crizotinib; Renal cell carcinoma; Oncology; Internal medicine; Papillary renal cell carcinomas; Urology; Carcinoma; Foolishness; Psychology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002195633,0.002556613,0.004897812,0.00054,0.0004483447,0.001536548,0.001193758,0.00256383,0.007908331],"category_scores_gemma":[0.002628998,0.0008918976,0.004182882,0.0005469937,0.001268122,0.00177457,0.0004627615,0.00448746,0.001341403],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001628212,"about_ca_system_score_gemma":0.001322965,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002131412,"about_ca_topic_score_gemma":0.005158985,"domain_scores_codex":[0.9989628,0.0005387964,0.00006132968,0.0002065613,0.00008595498,0.0001445895],"domain_scores_gemma":[0.9988924,0.0004188332,0.0002316983,0.00008153125,0.00007296672,0.0003025503],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9855992,0.001026825,0.0002074373,0.0007654598,0.001811225,0.0000290802,0.00003205513,0.0002933092,0.001042059,0.0001029909,0.0007438798,0.008346438],"study_design_scores_gemma":[0.9780611,0.01933402,0.0007705376,0.00003414678,0.0007030627,0.00003510293,0.00001902921,0.0002461397,0.0001195337,0.000169981,0.0004925448,0.0000148982],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9538357,0.03124479,0.0009963094,0.002335107,0.002542571,0.002556007,0.002167933,0.0002547039,0.00406698],"genre_scores_gemma":[0.9812523,0.007181921,0.001340321,0.001666306,0.0007849893,0.00182584,0.001594084,0.00004375351,0.004310478],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007908331,"threshold_uncertainty_score":0.02645606,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1253189226571554,"score_gpt":0.3859075263052156,"score_spread":0.2605886036480602,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}